• Profile
Close

Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanoma

Human Pathology Feb 25, 2018

Xu T, et al. - This study was conducted in order to comparatively explore the gene expression profiles of primary and lymph node metastatic acral melanoma (AM) tissues. In contrast with the primary tumors, the expression levels of 396 genes were increased, and that of 766 genes were decreased in the metastatic tissues. Based on the yielded data, experts defined the gene expression signature of AM metastasis and illustrated that cell division cycle-associated 5 (CDCA5) served as a potential therapeutic target in AM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay